Clinical trial
iCLAS™ for Persistent Atrial Fibrillation
NCT04061603 is registered in ClinicalTrials.gov with Adagio Medical as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- iCLAS™ for Persistent Atrial Fibrillation
- Lead sponsor
- Adagio Medical
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 9, 2019
- Completion date
- August 30, 2024
- Enrollment
- 215 (actual)
- Sites
- 21
Conditions
As the registry lists them; a condition with its own page is linked.
persistent atrial fibrillation